European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
European watchdog partially approves new Alzheimer's drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...
TASS12h
Negotiations on new European Commission stalled, December 1 deadline at risk — media
ROME, November 14. /TASS/. Talks on the makeup of the new European Commission proposed by its President Ursula von der Leyen have reached an impasse and may not be resolved by December 1, when the ...
about.fb14h
Our Response to the European Commission’s Decision on Facebook Marketplace
The European Commission’s decision provides no evidence of competitive harm to rivals or any harm to consumers.